NVS Trademark

Trademark Overview

On Wednesday, June 27, 2018, a trademark application was filed for NVS with the United States Patent and Trademark Office. The USPTO has given the NVS trademark a serial number of 88978527. The federal status of this trademark filing is REGISTERED as of Tuesday, October 6, 2020. This trademark is owned by Novelstar Pharmaceuticals Inc.. The NVS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services and pharmaceutical product evaluation services; providing services to others relating to analytical, chemistry and manufacturing controls for regulatory approval of small and large molecules drug products, namely, providing scientific information relating to the analysis and management of the drug manufacturing process for regulatory approval of small and large molecules drug products
nvs

General Information

Serial Number88978527
Word MarkNVS
Filing DateWednesday, June 27, 2018
Status700 - REGISTERED
Status DateTuesday, October 6, 2020
Registration Number6171448
Registration DateTuesday, October 6, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a circle with enclosed stylized text which reads "NVS".
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services and pharmaceutical product evaluation services; providing services to others relating to analytical, chemistry and manufacturing controls for regulatory approval of small and large molecules drug products, namely, providing scientific information relating to the analysis and management of the drug manufacturing process for regulatory approval of small and large molecules drug products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 1, 2018
Primary Code042
First Use Anywhere DateMonday, December 31, 2018
First Use In Commerce DateSaturday, August 31, 2019

Trademark Owner History

Party NameNovelstar Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
Party NameNovelstar Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
Party NameNovelstar Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events

Event DateEvent Description
Tuesday, October 6, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, August 29, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, August 28, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 13, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, August 12, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 7, 2020USE AMENDMENT FILED
Wednesday, August 12, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, July 7, 2020DIVISIONAL REQUEST RECEIVED
Thursday, August 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 7, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, July 7, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 26, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, July 11, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 16, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 16, 2019ASSIGNED TO LIE
Wednesday, May 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, April 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, April 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 23, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 23, 2018NON-FINAL ACTION WRITTEN
Thursday, October 18, 2018ASSIGNED TO EXAMINER
Tuesday, July 3, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, July 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 30, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

drug services pharmaceutical products molecules manufacturing regulatory small approval relating